Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Moodys
McKinsey
Medtronic
Boehringer Ingelheim

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Diphencyprone

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Diphencyprone?

Diphencyprone is an investigational drug.

There have been 4 clinical trials for Diphencyprone. The most recent clinical trial was a Phase 1 trial, which was initiated on March 14th 2017.

The most common disease conditions in clinical trials are Hypersensitivity, Delayed, Hypersensitivity, and Melanoma. The leading clinical trial sponsors are Innovaderm Research Inc., Rockefeller University, and Brickell Biotech, Inc.

There are eighty-six US patents protecting this investigational drug and five hundred and eighty-three international patents.

Recent Clinical Trials for Diphencyprone
TitleSponsorPhase
Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy VolunteersInnovaderm Research Inc.N/A
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact DermatitisBrickell Biotech, Inc.Phase 1
Effect of RANKL Inhibition on UV-induced ImmunosuppressionInnovaderm Research Inc.Phase 1

See all Diphencyprone clinical trials

Clinical Trial Summary for Diphencyprone

Top disease conditions for Diphencyprone
Top clinical trial sponsors for Diphencyprone

See all Diphencyprone clinical trials

US Patents for Diphencyprone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Diphencyprone   Start Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Start Trial
Diphencyprone   Start Trial Topical compositions and methods for making and using same SEBELA INTERNATIONAL BERMUDA LIMITED (Hamilton, BM)   Start Trial
Diphencyprone   Start Trial Topical compositions and methods for making and using same SEBELA INTERNATIONAL BERMUDA LIMITED (Hamilton, BM)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Medtronic
Moodys
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.